As behavioral health expands access and continues to trend toward more parity with physical health, the focus is moving from just counting how many people get care to asking whether that care is actually improving lives. How behavioral health organizations consistently and clearly answer that question is now the key challenge.
The effectiveness of treatment varies broadly, and there is no lab finding or other objective test that demonstrates efficacy. When we don’t routinely track outcomes, clinicians, health systems, and policymakers lose visibility into what’s working, where care can improve, and which interventions deliver the greatest benefit.
Measurement-based care (MBC) helps fill that gap. It gives us a structured way to track patient progress and use that information to guide care. But for MBC to become standard practice, policy must encourage its use.
Measurement-Based Care Is More Than a Metric
MBC is the practice of regularly using validated tools — such as the PHQ-9 for depression and the GAD-7 for anxiety. These short, standardized questionnaires ask patients about the frequency and severity of their symptoms and generate scores that can be tracked over time. By providing a standardized measure of symptom change, they offer an objective way to monitor a patient’s condition and guide treatment decisions throughout care.
For clinicians, the benefits are clear. Rather than relying solely on recall and intuition, we have a consistent reference point for every conversation. Data adds another valuable dimension to our clinical understanding, providing actionable insights that help guide treatment decisions.
At its core, MBC helps to inform our clinical decisions and helps us deliver care that’s more responsive to each patient’s needs.
Research Puts Numbers to the Promise
MBC is only as valuable as what we do with the information it provides. At Family Care Center, we use PHQ-9, GAD-7, and other assessment tools as part of routine clinical care to guide treatment decisions. Because those measures are already embedded in how we work, they also give us a meaningful way to evaluate outcomes across our system.
A recent multi-site Family Care Center study, published in Psychiatric Services, evaluated outcomes for patients receiving medication management, psychotherapy, and transcranial magnetic stimulation (TMS). PHQ-9 and GAD-7 scores served as the primary measures of improvement.
The findings were encouraging, with 76% of patients demonstrating clinical improvement in depression symptoms within 44 days. On average, patients reached remission in 70 days. Both outcomes exceeded national industry benchmarks.
The study also reinforced something many of us see every day: integrated, multi-disciplinary care matters. Patients who received all three treatments were 91% more likely to improve or reach remission than those who received only one. Patients who received TMS were 53% more likely to achieve remission than those who did not.
None of these insights would have been possible without routine measurement. We didn’t collect PHQ-9 and GAD-7 scores for research purposes — we collected them because our clinicians needed a reliable way to track progress and make informed decisions. The research came from the care itself.
This is one of the strongest and most often missed benefits of measurement-based care. When outcome measures are collected regularly across a health system, they build a growing set of real-world evidence that goes beyond individual visits. By looking at this combined data, we can see which treatments work best, spot gaps in care, and find ways to improve clinical processes and use resources more effectively.
You Can’t Improve What You Don’t Measure
Today, we often measure quality through process metrics such as appointment attendance, screening rates, and documentation requirements. These have value, but they don’t tell us whether a patient’s depression lifted, whether anxiety symptoms decreased, or whether treatment helped someone return to work, reconnect with family, or function more fully in daily life.
MBC helps close that gap. It gives clinicians a clearer picture of patient progress and helps health systems understand which treatments produce meaningful outcomes.
This difference matters more as healthcare shifts to value-based care, which rewards better patient outcomes, quality, and cost-effectiveness instead of just the number of services provided. Without solid outcomes data, it is hard for providers, health systems, employers, and payers to know if behavioral health interventions are truly valuable.
When symptoms and functioning are measured regularly over time, MBC provides a way to track progress, improve care, and make better decisions.
Better Data Means Lower Costs
There’s also a strong financial case for measuring outcomes. When we identify limited progress early, we can adjust treatment before symptoms worsen — reducing the risk of emergency visits, hospitalizations, disability claims, and the other costly consequences of undertreated behavioral health conditions.
For payers and employers, better outcomes aren’t just a quality goal. They’re a cost-containment strategy.
The Barriers Are Structural, Not Clinical
If MBC offers such clear benefits, why isn’t it standard practice across behavioral health?
The challenge isn’t clinical interest. Most providers already believe we should measure outcomes. The challenge is building systems that make measurement practical, sustainable, and meaningful.
Many electronic health records still make outcome tracking cumbersome. Providers rarely receive reimbursement for the time they spend administering, reviewing, and acting on outcome measures. And because organizations often use different tools, we struggle to compare results or learn from one another.
These barriers are solvable. Policymakers and payers can reward outcomes rather than volume alone. Value-based contracts can establish routine measurement as a core expectation of quality care. Greater standardization of outcome measures can help us compare results, identify best practices, and better understand what works across different populations and settings.
Behavioral health has made meaningful progress in expanding access to care. Our next challenge is ensuring that care consistently leads to better outcomes.
MBC gives us a way to see whether we’re achieving that goal. Policy can help make it the norm by building systems that support, reward, and sustain the measurement of outcomes that matter most to our patients.
Christopher Ivany, MD, is a psychiatrist and the CEO of Family Care Center.
